Capital Flow Monitor · Sponsors · CIK 2100543
Faeth Therapeutics, Inc.
701 TILLERY ST #12 #1010, AUSTIN, TX, 78702 · 510-858-1839
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$25.0M
Sold
$24.4M
% sold
97.7%
Investors
35
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-01-27 | D ·current | 506(b) | $25.0M | $24.4M | 97.7% | 35 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Anand Parikh — Executive Officer / Director / Promoter, Austin, TX
-
Jayson Dallas — Director, Austin, TX
1 other raise
- Galecto, Inc. $285.0M of $285.0M · 100.0%
- Oliver Maddocks — Executive Officer / Director, Austin, TX
-
Robert Gould — Director, Austin, TX
1 other raise
- Spinnaker Lincoln Park LLC $4.0M of $4.0M · 100.0%
-
Alex Morgan — Director, Austin, TX
2 other raises
- Opentrons Labworks Inc. $20.1M of $56.6M · 35.5%
- Gather Health Primary Care, Inc. $21.2M of $25.0M · 84.8%
- Stephen Hahn — Director, Austin, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.